We are
reimagining clinical trials
Vial was founded on a mission to reimagine clinical trials and deliver faster and more efficient trials for sponsors.
Vial's vision is to empower scientists
to cure all human disease.
Vial is a next-generation CRO that delivers faster and 50%+ cheaper trials through an end-to-end technology platform.
Meet Our Team
Clinical Operations expertise meets product minds from Silicon Valley — together, the team has developed Vial’s technology platform that delivers dramatically faster and more efficient trials for sponsors.
Carlos Naranjo Director of Sales
Etunim Mike Clinical Trial Lead
Our Investors
We have raised $100M+ and built a team of ClinOps and technology leaders in order to become a leading global, full-service CRO.
Scientific Advisory Board
Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.
Dr. Guru Sonpavde
Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Dr. Neeraj Agarwal
Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
Dr. Arshad Khanani
Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates
Dr. Mark Lebwohl
Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology at the Mount Sinai Hospital in New York City
Dr. Luke Nordquist
CEO at Urology Cancer Center and XCancer Research
Dr. Arvind Chaudhry
Director of Summit Cancer Centers, Medical Oncologist
Dr. Roberta Brinton
Director of the Center for Innovation in Brain Science at The University of Arizona and founder of NeuTherapeutics.​
Dr. David Pariser
Senior physician of Pariser Dermatology Specialist and Principal Investigator
Dr. Arati Rao
Head of Clinical Development at PACT Pharma
Dr. Antoni Ribas
Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)
Dr. Joseph Merola
Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School
Dr. Paul Karpecki
Director of Corneal Services at Kentucky Eye Institute and Faculty Associate Professor at the University of Pikeville, Kentucky, College of Optometry.
Dr. Nathan Pennell
Professor of Medicine and the Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute
Dr. Jonathan Zung
Chief Development Officer at Evelo Biosciences
Dr. Egilius L.H. Spierings
Founder, Medical Director, and Investigator at MedVadis Research Corporation
Dr. Rajat N Agrawal
VP of Clinical Development and Ophthalmology Lead at Rezolute, Inc.
Dr. Stewart Tepper
Professor of Neurology and Neurologist at the Dartmouth-Hitchcock Medical Center
Dr. Jacqueline French
Professor of Neurology at the Comprehensive Epilepsy Center at NYU Grossman School of Medicine and the President, Director, and Founder of The Epilepsy Study Consortium.
Dr. Christopher Sweeney
Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) and Professor of Medicine at the University of Adelaide
Dr. Peter Goadsby
Director of the NIHR Wellcome Trust at the King's College Clinical Research Facility and Professor of Neurology at the University of California, San Francisco
Dr. Veeral Sheth
Director of Clinical Research at the University Retina and Macula Associates and a Clinical Assistant Professor at the University of Illinois
Dr. Michael W. Lawlor
Professor at the Medical College of Wisconsin and the Founder, Owner, and CEO of Diverge Translational Science Laboratory
Dr. Adam Friedman
Professor and Chair of Dermatology, Residency Program Director of Translational Research, and Director of Supportive Oncodermatology at George Washington University
Dr. Marc Hoffmann
Medical Director for Lean and Quality Improvement, Chair of the Lymphoma/Myeloma Disease Working Group, and Associate Professor at the University of Kansas
Dr. Rajesh Pahwa
Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center
Dr. Joseph Jankovic
Professor of Neurology and Director of the Parkinson's Disease Center and Movement Disorders Clinic at the Baylor College of Medicine.
Dr. Robert A. Hauser
Director of the Parkinson’s Disease and Movement Disorder Center and a Professor of Neurology, at the University of South Florida
Dr. H. Jack West
Clinical Executive Director at AccessHope
Dr. Eric Jonasch
Genitourinary Medical Oncology Professor and Physician at The University of Texas MD Anderson Cancer Center, Houston, TX
Dr. Brian Rini
Chief of Clinical Trials at Vanderbilt University
We’re building a technology platform and products we believe in
We found our calling in clinical trials after learning the pain points directly. Our curiosity propels us to keep building, finding new challenges, and fulfilling our vision of reimagining clinical trials.
Talk to Sales
Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.
